The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-(4-(4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)-2-(pyrrolidin-2-yl)ethanone ID: ALA4555271
PubChem CID: 155556073
Max Phase: Preclinical
Molecular Formula: C25H31F2N9O2
Molecular Weight: 527.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(C[C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1
Standard InChI: InChI=1S/C25H31F2N9O2/c26-21(27)22-29-18-5-1-2-6-19(18)36(22)25-31-23(30-24(32-25)35-12-14-38-15-13-35)34-10-8-33(9-11-34)20(37)16-17-4-3-7-28-17/h1-2,5-6,17,21,28H,3-4,7-16H2/t17-/m0/s1
Standard InChI Key: GOJHJBFUANKGFP-KRWDZBQOSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
3.3735 -19.6745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3723 -20.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0871 -20.9147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8036 -20.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8007 -19.6709 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0853 -19.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0829 -18.4368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7941 -18.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7936 -17.2038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0797 -16.7896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3647 -17.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3635 -18.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6576 -20.9138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5186 -20.9128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9027 -20.5791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3502 -21.1918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5157 -21.7379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2267 -22.1492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9429 -21.7391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9436 -20.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2280 -20.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5692 -21.7356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7622 -21.9043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5064 -22.6859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0564 -23.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8657 -23.1264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1177 -22.3449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7308 -19.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3437 -19.2200 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.9461 -19.5176 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.6564 -22.1532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3718 -21.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0853 -22.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1724 -22.9743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9789 -23.1475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3931 -22.4340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8423 -21.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6546 -22.9782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
2 13 1 0
4 14 1 0
13 15 1 0
15 16 2 0
16 23 1 0
22 13 1 0
14 17 1 0
14 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
15 28 1 0
28 29 1 0
28 30 1 0
19 31 1 0
31 32 1 0
33 32 1 6
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 33 1 0
31 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.58Molecular Weight (Monoisotopic): 527.2569AlogP: 1.78#Rotatable Bonds: 6Polar Surface Area: 104.54Molecular Species: BASEHBA: 10HBD: 1#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 10.62CX LogP: 2.88CX LogD: -0.06Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.51Np Likeness Score: -1.11
References 1. Miller MS, Mountford SJ, Pinson JA, Zheng Z, Künzli M, Patel V, Hogg SJ, Shortt J, Jennings IG, Thompson PE.. (2016) Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ., 26 (19): [PMID:27561716 ] [10.1016/j.bmcl.2016.08.028 ]